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ABSTRACT
Purpose To analyse and compare the classiﬁcation of
eyes with diabetic retinopathy using ﬂuorescein
angiography (FA) and optical coherence tomography
angiography (OCTA) performed either with AngioPlex or
AngioVue.
Methods This was an observational cross-sectional study
of 50 eyes from 26 diabetic subjects. Two independent
graders classiﬁed the FA angiograms, to assess the
presence and severity of several characteristics according to
the ETDRS Report 11, and a similar evaluation was
performed for each 3×3 mm OCTA image from the
superﬁcial retinal layer and for the full retina slab.
Results Percentages of non-gradable images for the
outline of foveal avascular zone (FAZ) in the central
subﬁeld (CSF) were 29.0% for FA, 12.0% for AngioVue
and 3.0% for AngioPlex. For capillary loss, percentages of
non-gradable images in the CSF were 25.0% for FA, 11%
for AngioVue and 0.0% for AngioPlex. For the inner ring
(IR), percentages of non-gradable images were 12.5% for
FA, 11.5% for AngioVue and 0.5% for AngioPlex.
Agreement between graders was substantial for outline of
FAZ. For capillary loss, the agreement was fair for the CSF,
and moderate for the IR.
Conclusions The OCTA allows better discrimination of
the CSF and parafoveal macular microvasculature than FA,
especially for FAZ disruption and capillary dropout,
without the need of an intravenous injection of
ﬂuorescein. In addition, FA had also a higher number of
non-gradable images. The OCTA can replace with
advantage the FA, as a non-invasive and more sensitive
procedure for detailed morphological evaluation of central
macular vascular changes.
Trial registration number NCT02391558,
Pre-results.
INTRODUCTION
The use of ﬂuorescein angiography (FA) was ﬁrst
described in 19611 and introduced as a widespread
technique by Gass et al2 in 1967. It has been the
gold standard for evaluating vascular alterations
that occur in different stages of diabetic retinopathy
(DR). Those alterations have been evaluated in a
systematic fashion, and a classiﬁcation system was
developed to assess severity of selected character-
istics such as capillary loss and dilatation, size of
foveal avascular zone (FAZ), arteriolar abnormal-
ities and several other features based on the obser-
vation of the angiograms by the ETDRS Group.3
However, reproducibility of grading is still
problematic4 and despite the additional informa-
tion from FA, the Diabetic Retinopathy Study
(DRS) and ETDRS still rely on the interpretation of
stereo fundus photography5 for assessing severity
scale and the need for laser photocoagulation.6 In
addition, FA is invasive, involves risks and can
cause nausea or allergic reactions.7 With the recent
development of optical coherence tomography
angiography (OCTA),8–17 which is based on the
principle of identifying temporal changes of OCT
signal, caused by ﬂowing of the erythrocytes in
blood vessels, a new method for visualisation of the
retinal microvasculature emerged. This technique
allows the construction of three-dimensional blood
ﬂow information, and therefore can serve as a non-
invasive method to evaluate ocular circulation.
In this study, we aimed to compare gradings of
vascular changes of eyes with DR, using FA and
OCTA, following ETDRS Report 11 methodology.
The comparison focused on the superﬁcial
retinal layer, because an exact comparison cannot
be made between both methods for the deeper
layer, as the deep retinal layer is not distinguishable
with FA.18 However, a comparison was also per-
formed between FA and OCTA full retina slab.
MATERIALS AND METHODS
Participants
The tenets of the Declaration of Helsinki were fol-
lowed and informed consent to participate in the
study was obtained from all subjects after all proce-
dures were explained. This was an observational
cross-sectional study. The study was performed at
the Association for Innovation and Biomedical
Research on Light and Image from September
2015 through December 2015 (http://www.
clinicaltrials.gov NCT02391558) and included 26
patients with different levels of DR. Patients with
any other chorioretinal disease, history of vitreous
surgery or severe media opacity, such as dense cata-
ract or vitreous haemorrhage, and high ametropic
eyes (sphere dioptres >6 and cylinder dioptres >3)
were excluded to ensure good quality images.
All the patients underwent a complete ophthal-
mological examination, including best-corrected
visual acuity and intraocular pressure assessment,
dilated fundus examination, 7-ﬁeld colour fundus
photography (CFP) (according to the ETDRS
grading protocol), FA (Heidelberg Spectralis,
Heidelberg, Germany) and OCTA (Zeiss Cirrus
5000 AngioPlex and Optovue RTVue AngioVue
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System). The values of haemoglobin A1c and duration of dia-
betes were recorded for analysis. ETDRS grade was determined
from 7-ﬁeld CFP (Topcon Medical Systems).
No patients with clinical macular oedema according to
DRCR.net OCT deﬁnition (≥305 mm—males/≥290 mm—
females) for Cirrus high deﬁnition (HD)-OCT were included.
FA was performed with the Spectralis Heidelberg retina
angiograph+OCT (Heidelberg Engineering, Heidelberg,
Germany) system, and clear and focused 20° images of the early
stage of the procedure were obtained. Patients were given a
3 mL intravenous injection of ﬂuorescein solution.
Optical coherence tomography angiography
OCTA was performed using two different devices. The Optovue
RTVue XR Avanti AngioVue software uses the split-spectrum
amplitude decorrelation angiography algorithm.11 This instru-
ment has a 70 kHz axial scan repetition rate, using a light source
centred on 840 nm and a bandwidth of 50 nm. The optical axial
resolution is 5 mm, and the transverse is 15 mm. Each OCTA
volume contains 304×304 A-scans with two consecutive B-scans
(M-B frames) captured at a ﬁxed position before proceeding to
the next sampling location. The volumes were registered and the
B-scan images were compared to calculate the decorrelation in
the images along with motion artefact removal.
The scanning area was captured in 3×3 mm sections and was
centred on the fovea.
The volume data gathered was segmented using the internal
limiting membrane (ILM) as a plane of reference, with an inner
boundary at 3 mm beneath the ILM and the outer boundary was
set at 15 mm beneath the inner plexiform layer (IPL) in order to
obtain images of the superﬁcial retinal layer (SRL). An add-
itional segmentation was manually performed for the whole
neurosensory retina, generating a slab from the ILM to the
retinal pigment epithelial (RPE) that includes both superﬁcial
and deep plexus.
The other instrument used for the OCTA images was based on
the Zeiss Cirrus HD-OCT 5000. This instrument has a 68 kHz
axial scan repetition rate. The axial and transverse resolution in
tissue is 5 and 15 mm, respectively. AngioPlex is a new technol-
ogy based on the optical microangiography complex15 16 algo-
rithm. AngioPlex uses amplitude and phase aspects of the OCT
signal to extract in vivo blood ﬂow information. The scans com-
prise a series of clusters of repeated B-scans, where each B-scan
consists of 245 A-scans. Tracking on Cirrus is provided by regis-
tering fundus images provided by the line-scan ophthalmoscope
(LSO) image. This image is inherently registered to the OCT
data by using the same optical path. Images are acquired at a rate
of 15 Hz. Any OCT B-scans that were acquired during an LSO
frame that is offset by >30 mm from the reference LSO frame
are discarded and that region of the retina is re-acquired.19
The OCT volume scan had dimensions of 3×3 mm and
2 mm deep. The averaged OCT B-scans were segmented to
obtain the ILM and RPE. The inner retina was estimated as
being the tissue between the ILM and an offset from the RPE of
110 mm. The SRL was deﬁned as the inner 70% of the inner
retina. A preset slab of the entire retina was also assessed for
direct comparison with FA.
Low-quality images were graded conservatively, and consid-
ered non-gradable when the characteristic evaluated was not
perceived. OCTA images were excluded from analysis if the
Figure 1 Comparison of ﬂuorescein angiography (FA) with optical coherence tomography angiography (OCTA) images for the superﬁcial retinal
layer (AngioPlex and AngioVue). (A) Early 20° FA image. The white square outlines the area of the 3×3 mm graded for this study. (B) 3×3 mm OCT
angiogram obtained from Zeiss AngioPlex showing areas of non-perfusion (star) and microaneurysms (arrows). (C) 3×3-mm OCTA from AngioVue
showing the same areas of non-perfusion found for AngioPlex images, but with absence of microaneurysms. (D) Magniﬁcation of the 3×3 mm
square with grid overlaid. Arrows show a higher number of microaneurysms seen on FA in comparison with AngioPlex and AngioVue. 3×3 mm
angiograms from AngioPlex (E) and AngioVue (F) are overlaid with grid replicating the central subﬁeld and inner ring of the ETDRS grid.
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signal strength was below 60 for AngioVue or 6 for AngioPlex
or if motion artefacts were present.
Image arrangement for grading
In order to evaluate and compare the images obtained from the
three different devices, all the images were exported and a new
layer was added to the original image (ﬁgure 1). The layer was
developed using Gimp V.2.8.1 (gimp.org) and consists of two
solid-line concentric circles centred on the fovea. The radius of
the innermost solid-line circle corresponds to 500 mm, and the
second circle to 1500 mm. This presentation replicates the inner
ring of the ETDRS grid and is divided in ﬁve subﬁelds: CSF, IR
—superior, inferior, nasal and temporal. The enface images for
OCTA, and 20° images for FA, were loaded into Gimp. The
grid was then overlaid manually by one of the authors, and the
composed image graded. Areas corresponding to the subﬁelds
were analysed. FA images were magniﬁed and cropped to match
the OCTA images. No co-registration was performed.
Grading
Grading of the images was done based on an established
grading protocol3 accounting for different characteristics.
Several reference images were chosen for deﬁnition of the
boundaries between steps in the grading scale (ﬁgures 2 and 3).
The OCT and FA angiograms were then independently evalu-
ated by two trained readers.
The 3×3 mm OCT angiograms from the SRL and full retina
slab of both devices, and the 20° FA images (cropped to match
the area from OCTA) were evaluated for the following
characteristics: outline of FAZ, capillary loss and number of
microaneurysms (MAs). The grading for FA and OCTA angio-
grams was performed independently to avoid bias. Arteriolar
abnormalities (focal narrowing, narrowing or pruning and
arteriolar contour) were not graded because the identiﬁcation
of these features in OCTA images was too ambiguous in many
aspects: (1) due to the lack of references for the course of the
arterioles and venules in the 3×3 mm parafoveal area; (2) the
speciﬁcity of the classiﬁcation—only side branches that are
perpendicular to parent arterioles are considered; (3) the
existence of speciﬁc characteristics in FA—leakage and stain-
ing—which are not present on the OCTA angiograms.
Capillary dilatation was also not evaluated due to the difﬁculty
in detecting such feature on OCTA, and RPE defects were not
evaluated because the segmentation was not performed for
that layer.
The outline of FAZ was graded as follows: grade 0=outline
normal; grade 1=outline not smoothly round or oval, appre-
ciable irregularities seen, but not necessarily abnormal; grade
Figure 2 Comparison of ﬂuorescein angiography (FA) with optical coherence tomography angiography (OCTA) images for the superﬁcial retinal
layer (AngioPlex and AngioVue) for foveal avascular zone and its outline. (A) 3×3-mm FA image of a diabetic eye showing poorly deﬁned FAZ due
to the presence of leakage from nearby microaneurysms. (B) 3×3 mm OCT angiogram (AngioPlex) from the same eye showing detailed outline of
the FAZ with adjacent areas of non-perfusion providing lower boundary for grade 3 (moderate) in central subﬁeld (outline destroyed for one-half or
more of the original circumference, but some remnants remain). (C) 3×3 mm OCT angiogram from AngioVue showing the same characteristics
observed in Zeiss AngioPlex images.
Figure 3 Comparison of ﬂuorescein angiography (FA) with optical coherence tomography angiography (OCTA) images for the superﬁcial retinal
layer (AngioPlex and AngioVue). (A) 3×3 mm FA image of a diabetic eye showing presence of multiple microaneurysms concentrated in the inferior
and temporal subﬁeld of the inner ring (IR) (arrows). (B) 3×3 mm OCT angiogram (AngioPlex) showing less microaneurysms than FA images, but
with capillary non-perfusion areas more deﬁned—squares—(temporal and nasal subﬁeld of the IR) comparing with FA image. (C) 3×3 mm OCT
angiogram (AngioVue) showing less microaneurysms than AngioPlex images. Areas of non-perfusion are also well deﬁned, setting lower boundary
for grade 2 (deﬁnitive) in all subﬁelds of the IR.
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2=obviously damaged, <180°; grade 3=obviously damaged,
>180°, some remnants; grade 4=outline totally destroyed;
grade 8=cannot grade.
Capillary loss was graded for the CSF, and the inner ring of
the ETDRS grid, divided in four subﬁelds (superior, inferior,
nasal and temporal) according to the scale: grade 0=absent;
grade 1=questionable; grade 2=deﬁnitive (up to 25% loss in
the subﬁeld); grade 3=moderate (>25% and up to 50% loss in
the subﬁeld); grade 4=severe (>50% loss in the subﬁeld); grade
8=cannot grade.
MA counting was also performed for all the subﬁelds considered.
MAs were deﬁned as distinctly round, saccular or fusiform hyper-
ﬂuorescent spots as described for early phase FA and on OCTA,20 21
as localised dilatations connected to the retinal capillaries.
Statistics
Original scales of outline of FAZ, and capillary loss were
recoded in dummy variables for two separate analyses: graded
versus cannot grade and normal versus abnormal. Outline of
FAZ and capillary loss were considered graded when the original
grade ranged from 1 to 4 and cannot grade when the original
grade was 8. Outline of FAZ was considered normal when the
original grade ranged from 0 to 1 and abnormal when the ori-
ginal grade ranged from 2 to 4. Capillary loss was considered
normal when the original grade was 0 and abnormal when the
original grade ranged from 2 to 4. Grades questionable or
cannot grade were excluded from the normal versus abnormal
analysis. Exact agreement and Cohen’s κ coefﬁcient were calcu-
lated to assess the agreement between graders and between
methods. Categorical variables are summarised with percentages
and numerical variables with mean±SD.
RESULTS
A total of 50 eyes from 26 subjects with mean age of 65 (SD 7)
with DR were imaged using FA and OCTA. A summary of the
characteristics of the subjects and eyes, and the stage of DR is
shown in table 1.
Outline of FAZ
For outline of FAZ in FA, the percentage of non-gradable images
was 29.0%. There was exact agreement for 78% of the eyes graded
(κ 0.712); when using graded versus cannot grade, complete agree-
ment increased to 94% (κ 0.854); for normal versus abnormal ana-
lysis, the percentage of agreement was 88% (κ 0.757).
In the AngioVue, the percentage of non-gradable images was
12.0%. The percentage of agreement was 72% of the eyes
graded (κ 0.629); when using graded versus cannot grade ana-
lysis, the complete agreement was 100% (κ 1.000); for normal
versus abnormal analysis, the percentage was 88% (κ 0.760).
In the AngioPlex, the percentage of non-gradable images was
3.0%. The percentage of agreement was 76% of the eyes graded
(κ 0.659); when using graded versus cannot grade analysis, the
complete agreement was 98% (κ 0.657); for normal versus
abnormal analysis, the percentage was 87% (κ 0.746).
For method analysis, when comparing for gradable/non-
gradable images, the percentage of agreement was 72.0% for FA
versus AngioPlex, 71.0% for FA versus AngioVue and 85.0% for
AngioPlex versus AngioVue.
On the other hand, when comparing normal versus abnormal
features, the percentage of deﬁnitive abnormal features found
was superior in both OCTA devices in comparison with FA:
29.0% for FA, 43% for AngioPlex and 33.0% for AngioVue.
The grading using the full retina slab showed a decrease of 2.0%
for AngioVue and 4.0% for AngioPlex in the percentage of cases
classiﬁed as abnormal in comparison with the SRL analysis.
Table 1 Characteristics of the study sample
Patients/eyes, n 26/50
Male/female, n 16/10
Age, years
Mean±SD 64.9±7.38
Range 52–76
Duration of diabetes, years
Mean±SD 18.7±6.9
Range 7–33
Haemoglobin A1c (%)
Mean±SD 7.7±1.9
Range 6.1–14.1
ETDRS level, no. eyes (%)
10 8 (16)
20 4 (8)
35 27 (54)
43 4 (8)
47 4 (8)
53 3 (6)
Figure 4 Comparison of ﬂuorescein angiography (FA) images with superﬁcial retinal layer (SRL) and full retina slab images for AngioPlex. (A) 3×3
mm FA image of a diabetic left eye showing presence of microaneurysms concentrated in the superior and temporal subﬁeld of the IR (arrows). (B)
3×3 mm OCT angiogram of the SRL (AngioPlex) showing less microaneurysms than FA images, but with capillary non-perfusion areas more deﬁned
—stars—(superior and inferior subﬁeld of the IR) comparing with FA image. (C) 3×3 mm OCT angiogram of the full retina slab (AngioPlex) showing
more microaneurysms than in SRL images (arrows). In the full retina slab, the areas of non-perfusion are now less deﬁned.
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Capillary loss: CSF
For capillary loss in the CSF using FA images, the percentage of
non-gradable images was 25.0%. Intergrader agreement for
capillary loss—CSF was lower than it was for outline of FAZ:
the exact agreement was 50% (κ 0.363); when using graded
versus cannot grade, the complete agreement increased to 90%
(κ 0.736); for normal versus abnormal analysis, the percentage
of agreement was 74% (κ 0.137).
In the AngioVue, the percentage of non-gradable images was
11.0%. The percentage of exact agreement was 62% of the eyes
graded (κ 0.496); when using graded versus cannot grade ana-
lysis, the complete agreement was 98% (κ 0.898); for normal
versus abnormal analysis, the percentage was 82% (κ 0.443).
In the AngioPlex, the percentage of non-gradable images was
0.0%. The percentage of exact agreement was 56% of the eyes
graded (κ 0.412); when using graded versus cannot grade ana-
lysis, the complete agreement was 100%; for normal versus
abnormal analysis, the percentage was 72% (κ 0.306).
For method agreement analysis, for gradable/non-gradable
images, the percentage of agreement was 75.0% for FA versus
AngioPlex, 72.0% for FA versus AngioVue and 89.0% for
AngioPlex versus AngioVue.
When comparing normal versus abnormal features, the per-
centage of deﬁnitive abnormal features found was 38.0% for
FA, 50.0% for AngioPlex and 40.0% for AngioVue.
For capillary loss in the CSF analysis of the full retina slab showed
a decrease of 12.0% for both AngioVue and AngioPlex, in the per-
centage of cases classiﬁed as abnormal when analysing the SRL.
Capillary loss: inner ring (parafoveal)
For capillary loss, the analysis of the four subﬁelds of the inner
ring of the ETDRS grid corresponding to parafoveal region was
aggregated for better discrimination and analysis. Using FA
images, the percentage of non-gradable images was 12.5%.
Intergrader agreement for capillary loss—inner ring, was 59.0%
(κ 0.411) for exact agreement of the characteristics; when using
graded versus cannot grade, the agreement increased to 92.0%
(κ 0.606); for normal versus abnormal analysis, the percentage
of agreement was 70.0% (κ 0.415).
In the AngioVue, the percentage of non-gradable images was
11.5%. The percentage of exact agreement was 75% of the eyes
graded (κ 0.655); when using graded versus cannot grade ana-
lysis, the agreement was 98% (κ 0.924); for normal versus
abnormal analysis, the percentage was 87% (κ 0.733).
In the AngioPlex, the percentage of non-gradable images was
0.5%. The percentage of exact agreement was 74% of the eyes
graded (κ 0.612); when using graded versus cannot grade ana-
lysis, the complete agreement was 99%; for normal versus
abnormal analysis, the percentage was 87% (κ 0.748).
For method agreement analysis, when comparing FA versus
OCTA for gradable/non-gradable images, the results showed
higher percentages in comparison with the ones obtained for
the CSF: the percentage of agreement was 87.7% for FA versus
AngioPlex, 81.0% for FA versus AngioVue and 88.7% for
AngioPlex versus AngioVue.
When comparing normal versus abnormal features, the per-
centage of deﬁnitive abnormal features found was 15.0% for
FA; 35.5% for AngioPlex and 24.5% for AngioVue.
For capillary loss in the IR analysis of the full retina slab, the
percentage of cases classiﬁed as abnormal decreased in compari-
son with the SRL analysis by 5.0% versus the AngioVue, and by
19.0% versus the AngioPlex. An example of this trend can be
observed in ﬁgure 4.
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MAs counting
The visualisation and counting of the MAs was compared
between the FA images and in both OCT angiography methods
looking at the SRL and full retina slab. A higher number of
MAs were found in FA images compared with both OCTA
devices in the SRL and full retina slab. For FA the mean number
of MAs counted was 5.9±5.8. For AngioVue in the SRL the
value was 1.0±1.7, and for full retina slab the mean number
was 2.0±3.1. For the AngioPlex, the mean number was 4.3
±4.2 in the SRL and 5.8±6.3 in the full retina slab. The
number of MAs detected in the OCTA full retina slab compar-
ing the MAs detected in FA was 34.0% for AngioVue and
98.0% for AngioPlex.
The agreement between graders for MAs counting was satis-
factory: for FA the exact agreement was 68% (κ 0.424), for
AngioPlex the exact agreement was 64% (κ 0.480) and for
AngioVue the agreement was 74% (κ 0.552).
Table 2 shows a summary of percentage of agreement and κ
values for grade versus non-gradable images, and for normal
versus abnormal agreement between graders for all character-
istics graded, for FA and OCTA.
Tables 3 and 4 summarises percentages of equipment agree-
ment and κ values for several characteristics in comparison with
FA/OCTA for both graders.
DISCUSSION
In this study, we tried to replicate the systematic assessment pro-
posed by the ETDRS Research Group for the analysis of FA
images. Comparison between FA images and OCT angiograms
was performed by two graders according to the severity of dif-
ferent characteristics found in the angiograms of patients with
different DR levels. The percentage of non-gradable images was
larger on FA images in comparison with both OCTA devices.
The image quality of FA is clearly affected by the contrast,
degree of pigmentation and media opacity22 and also for early
leakage and superimposition of all perfused layers and choroidal
blood vessels.21 On the other hand, OCTA images are affected
by eye motion, scan speed, media opacity and segmentation
errors that can cause several artefacts that may cause misinter-
pretation of the OCTA data.23
There are numerous differences between AngioVue and
AngioPlex that could lead to differences in the gradability
observed in this study. The two devices use different algorithms
to construct the ﬂow contrast image, but the comparability of
good images suggests that this image construction algorithm is
not the source of differences in gradability. The two devices
have different resolution (304×304 A-scans for AngioVue and
245×245 for AngioPlex), but this would presumably favour
AngioVue. AngioPlex has four repeated B-scans while AngioVue
has two, which may make the AngioPlex result more robust.
AngioPlex is based on a single scan, which uses live tracking to
reduce motion artefacts as discussed in the Material and
methods section. AngioVue is based on the combination of two
orthogonally acquired scans to reduce the effects of motion. In
both cases, there is a combination of multiple datasets to
improve robustness and a motion correction algorithm to
reduce motion artefacts. In the case of AngioVue, if neither of
the two scans contains relevant information, then some artefacts
will remain, and this may lead to some of the issues with
ungradability. Both methods will be subject to issues with the
media of the eye. Our experience suggests some advantage in
time to acquire the AngioPlex scan, which may affect the impact
of drying of the cornea on the quality of the image. Thus, the
most likely contributors to the improved gradability of
AngioPlex images are the beneﬁts of live eye tracking as
opposed to postacquisition motion correction as well as the ben-
eﬁts of a faster chin time in overall image quality. In this sample,
the visualisation and classiﬁcation of the FAZ, and the identiﬁca-
tion of areas of capillary dropout in the parafoveal area, showed
promising results with OCTA angiograms when focusing the
Table 3 Grader 1
Fluorescein angiography/AngioPlex Fluorescein angiography/AngioVue
Graded/cannot grade Normal/abnormal Graded/cannot grade Normal/abnormal
Characteristic
Exact
agreement (%) κ (p values)
Exact
agreement (%) κ (p values)
Exact
agreement (%) κ (p values)
Exact
agreement (%) κ (p values)
Outline of FAZ 70.00 0.083 (0.070) 82.35 0.650 (<0.001) 68.00 0.118 (0.157) 87.10 0.729 (<0.001)
Capillary loss (CSF) 70.00 0.000 (n.a.) 97.14 0.000 (0.500) 68.00 0.058 (0.304) 90.63 0.368 (0.004)
Capillary loss (IR) 85.50 0.000 (n.a.) 75.44 0.503 (<0.001) 79.00 0.043 (0.266) 71.43 0.427 (<0.001)
p Values are calculated from a McNemar test.
CSF, central subfield; FAZ, foveal avascular zone; IR, inner ring.
Table 4 Grader 2
Fluorescein angiography/AngioPlex Fluorescein angiography/AngioVue
Graded/cannot grade Normal/abnormal Graded/cannot grade Normal/abnormal
Characteristic
Exact
agreement (%) κ (p values)
Exact
agreement (%) κ (p values)
Exact
agreement (%) κ (p values)
Exact
agreement (%) κ (p values)
Outline of FAZ 74.00 0.068 (0.215) 77.78 0.544 (0.001) 74.00 0.181 (0.077) 70.59 0.411 (<0.007)
Capillary loss (CSF) 80.00 0.000 (n.a.) 75.00 0.431 (0.003) 76.00 0.117 (0.192) 69.44 0.220 (0.088)
Capillary loss (IR) 90.00 0.074 (0.029) 68.16 0.371 (<0.001) 81.00 0.030 (0.332) 57.23 0.160 (0.018)
p Values are calculated from a McNemar test.
CSF, central subfield; FAZ, foveal avascular zone; IR, inner ring.
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analysis on the SRL. We have found that when analysing the full
retina slab, areas graded as non-perfused in the SRL analysis
become less well-deﬁned and more difﬁcult to identify. The
whole retina analysis shows less sensitivity to capillary dropout
in comparison with the one obtained for the SRL. Nonetheless,
it is important to mention that for the features that were
graded, even with the full retina slab, OCTA shows better dis-
crimination of central and parafoveal microvasculature than FA,
for the capillary dropout and FAZ disruption analysis.
On the other hand, the full retina slab allowed viewing more
MA-like features than in the SRL analysis. The number of MAs
detected in the analysis performed using the OCTA full retina
slab was clearly closer to the MAs identiﬁed in FA. We can con-
clude that, when looking for number of MAs using OCTA and
looking for comparison with FA, it may be appropriate to use
the full retina slab.
The intergrader agreement was moderate to substantial in
several features. Other characteristics were not assessed with
OCTA such as arteriolar abnormalities and capillary dilatation,
particularly because in this study, most eyes had only mild non-
proliferative diabetic retinopathy. However, experience is
required, and for this training it is important to have reference
images with and without pathology to evaluate and discriminate
alterations found in DR.
It is noteworthy that several attempts have been made with
apparent success, in quantifying the degree of retinal capillary
dropout in the central macular area22 24 Our group has been
working in this area, and the initial results are very promising,
allowing separation between healthy eyes and eyes with mild
DR.25
FA and OCTA offer different perspectives for analysis of the
retinal vasculature. FA has been around for some time now, and
its interpretation is well established, whereas OCTA is just
beginning and its results need to be discussed and better under-
stood. Agreement on deﬁnition and characterisation of abnor-
malities detected is crucial. OCTA offers for the ﬁrst time
improved deﬁnition of the superﬁcial and deep retinal capillary
nets in the clinical setting. Analysis of the full retina slab on
OCTA examinations may help in the transition between FA and
OCTA.
Limitations of this study include the small number of patients
and eyes graded. The grading was also performed only by two
graders, and areas of disagreement were not reviewed in order
to achieve uniformity.
In conclusion, OCTA allows better discrimination of the CSF
and parafoveal macular microvasculature than FA, especially for
FAZ disruption and capillary dropout. OCTA appears to be
more sensitive and more reliable than FA in a clinical environ-
ment, allowing detailed morphological evaluation of the central
microvascular perfusion changes. In DR, characterisation of the
central microvascular perfusion changes is considered particu-
larly relevant regarding prognosis for vision loss and progression
to late-stage proliferative retinopathy.
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